|
Method | Procedure | Advantages | Disadvantages | Example | Reference |
|
Nanoparticles | | | | | [16–18] |
|
Evaporative precipitation into aqueous solution | Spraying of drug solution through an atomizer into an aqueous solution containing stabilizer at high temperature. | High dissolution rate, high surface area, enhanced wettability. | Require stabilizers, lack of controlled release, not suitable for thermolabile drugs | Nanosuspension of quercetin | [45] |
|
High pressure homogenization | Precipitation of drug by addition of antisolvent in the drug solution leading to formation of unstable form of drug which is stabilized by means of single/repeated application of high energy followed by thermal relaxation (annealing). | Reduced particle size, enhanced dissolution, no crystal growth | Long processing time, introduction of impurities, high energy requirements, chemical degradation | Nanosuspension of quercetin | [45] |
|
Antisolvent method | | | | | |
Antisolvent precipitation using a syringe pump | Addition of antisolvent to a solution of drug and solvent at a particular flow rate under constant stirring leading to precipitation of drug which is then filtered to collect nanoparticles. | Reduced particle size, high dissolution rate, high surface area, reduced crystallinity, faster onset of action | Contamination due to filtration | Nanoparticles of hesperetin | [65] |
Evaporative precipitation of nanosuspension | Mixing of a water miscible solvent containing drug with an antisolvent followed by evaporation of solvents. | Decreased particle size, enhanced surface area, improved dissolution | Particle growth due to remaining organic solvent in suspension | Curcumin nanoparticles | [92] |
Supercritical antisolvent method | Precipitation of drug from drug solution by mixing it with a compressed fluid at its supercritical conditions. Diffusion of solvent into antisolvent phase leads to drug precipitation due to low solubility of drug in antisolvent. | High product purity, controlled crystal polymorphism, possible processing of thermolabile molecules, single step process | Toxicity and flammability of solvents, poor control of particle morphology, incomplete removal of residual solvent | Apigenin nanocrystals | [55] |
|
Solid dispersion | Formation of eutectic mixtures of drugs with hydrophilic carriers by melting their physical mixtures | Particle size reduction, improved wettability, enhanced dissolution, higher porosity | Decrease in dissolution on aging, crystal growth upon moisture absorption, demixing, phase separation | Solid dispersion of ellagic acid | [19–21, 37] |
|
Self-microemulsifying drug delivery systems | Gentle mixing of drug, oil, surfactant, and cosurfactant in aqueous media leading to formation of o/w microemulsion of drug droplets with mean droplet size <100 nm. | Higher bioavailability, improved absorption, oral administration using gelatin capsules | Surfactant toxicity, tedious manufacturing method, interaction with capsule shell | Curcumin | [22, 23, 96] |
|